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Human oocytes and zygotes are 
ready for ultra-fast vitrification 
after 2 minutes of exposure to 
standard cpA solutions
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Vitrification of human oocytes and embryos in different stages of development is a key element 
of daily clinical practice of in vitro fertilization treatments. Despite the cooling and warming of the 
cells is ultra-fast, the procedure as a whole is time consuming. Most of the duration is employed in a 
long (8–15 minutes), gradual or direct exposure to a non-vitrifying cryoprotectant solution, which is 
followed by a short exposure to a more concentrated vitrifying solution. A reduction in the duration of 
the protocols is desirable to improve the workflow in the IVF setting and reduce the time of exposure 
to suboptimal temperature and osmolarity, as well as potentially toxic cryoprotectants. In this work 
it is shown that this reduction is feasible. In silico (MatLab program using two-parameter permeability 
model) and in vitro observations of the oocytes’ osmotic behaviour indicate that the dehydration upon 
exposure to standard cryoprotectant solutions occurs very fast: the point of minimum volume of the 
shrink-swell curve is reached within 60 seconds. At that point, intracellular water ejection is complete, 
which coupled with the permeation of low molecular weight cryoprotectants results in similar 
intracellular and extracellular solute concentrations. This shows that prolonging the exposure to the 
cryoprotectant solutions does not improve the cytosolic glass forming tendency and could be avoided. 
To test this finding, human oocytes and zygotes that were donated for research were subjected to a 
shortened, dehydration-based protocol, consisting of two consecutive exposures of one-minute to 
two standard cryoprotectant solutions, containing ethylene glycol, dimethyl sulfoxide and sucrose. 
At the end of this two-minute dehydration protocol, the critical intracellular solute concentration 
necessary for successful vitrification was attained, confirmed by the post-warming survival and ability 
to resume cytokinesis of the cells. Further studies of the developmental competency of oocytes and 
embryos would be necessary to determine the suitability of this specific dehydration protocol for clinical 
practice, but based on our results, short times of exposure to increasingly hypertonic solutions could be 
a more time-efficient strategy to prepare human oocytes and embryos for vitrification.
The vitrification technique is a key element of in vitro fertilization units’ daily clinical practice: over one 
hundred-thousand embryos and thirty-thousand oocytes originated in human assisted reproduction treatments 
were cryopreserved in Spain in 20151,2. The procedure relies on performing the cooling of the cells, and most 
importantly, the warming, at such high rates that the cytosol -and the extracellular solution in which the cell(s) 
are suspended- undergoes a second order phase transition to become an amorphous glass3. The water molecules 
in the cytosol do not have the necessary time, as temperature drops to a stable cryogenic range during cooling, 
and when it returns to room temperature during warming, to rearrange into ice crystals and grow to a size that 
can produce cellular injury or death. Instead, molecules remain in a similar disposition to the liquid state, but 
acquire the properties of a solid4. This liquid to solid transition, the glass transition, allows the cells’ structure 
and function to be preserved5–7. The chances of vitrification depend mostly on the speed at which cooling and 
warming occur, and the glass forming tendency of the solution, determined at large by its viscosity and solute 
concentration8,9.
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In the human embryology laboratory, oocytes and embryos are cryopreserved in vitrification carriers that, 
according to their design, will have variable thermal exchange rates10. The cytosol of oocytes and embryos’ blas-
tomeres, due to their large size and water content, does not vitrify at the rates currently attainable by those vitri-
fication carriers, unlike spermatozoa11. For that reason, the cells are subjected to a preparation protocol prior to 
cooling, in which they lose water and are permeated by low molecular weight cryoprotectants (CPAs), increasing 
the cytosol’s solute concentration, and hence its glass forming tendency8. As a result, the cooling and warming 
rates necessary to avoid deleterious ice formation are lower. Irrespectively of the vitrification carrier of choice, 
most preparation protocols to ready oocytes and embryos for vitrification are very similar12. They usually feature 
two or more exposure phases —gradual or direct— to increasingly hypertonic solutions composed of permeating 
and non-permeating CPAs. The composition of these solutions and the duration of the cell’s exposure to them is 
critical, as CPA toxicity is both time and concentration dependent13.
Despite shorter protocols have already been proposed9,14,15, most of currently employed protocols16–18 feature 
an initial long-exposure phase lasting from 8 to 15 minutes to a non-vitrifying solution: a solution with a concen-
tration of solutes that would not vitrify if cooled at the rates achievable with a specific carrier19. When exposed to 
hypertonic solutions, cells initially lose water and shrink to a minimum volume very rapidly. After that point, they 
slowly swell back towards their isotonic volume, as intra- and extracellular solute concentrations tend to osmotic 
equilibrium20. For this reason, this phase is usually termed equilibration. This is followed by a short exposure to 
a more concentrated solution, that vitrifies upon cooling at high rates (vitrification solution, VS)21. It is in this 
solution that the cells are suspended, loaded in the carrier device, and cooled. This exposure to VS is short, and 
cells are not allowed to equilibrate; they shrink, further dehydrated and permeated by cryoprotectants. The dura-
tion of the exposure has to be carefully controlled and limited to 60 seconds to avoid excessive osmotic effect8,22.
The equilibration of the cells, complete or partial, with non-vitrifying solutions during their preparation for 
vitrification is what contributes to most of the procedure’s duration and makes current protocols time consuming. 
However, shorter protocols of preparation of embryos and oocytes for vitrification are feasible: the critical cyto-
solic solute content necessary for successful vitrification at currently attainable cooling and warming rates can be 
achieved faster. In this work, using in silico data from a biophysical permeability model of human oocytes and in 
vitro osmotic observations, we propose a short, dehydration-based protocol. Using a standard set of vitrification 
solutions, we limit the duration of the exposure to one minute, when cells are close to the minimum volume point 
of their shrink-swell curve. We analyse the molarity of the cytosol of the dehydration protocol compared to a 
standard protocol, and test its efficacy on discarded human oocytes and abnormally fertilized zygotes donated 
for research.
Results
In silico analysis of the equlibration and dehydration protocols of human M-II Oocytes. The 
predicted relative volume and total intracellular solute concentration of oocytes subjected to two preparation 
protocols, the standard equilibration protocol (EP) and the short dehydration protocol (DP), as a function of 
time is shown on Fig. 1. Both protocols feature exposures to a non-vitrifying solution (nVS; 7.5% v/v Me2SO & 
7.5% v/v EG; 1.06 mol/L Me2SO & 1.12 mol/L EG) and a vitrifying solution (VS; 15% v/v Me2SO, 15% v/v EG and 
0,5 M sucrose; 2.11 mol/L Me2SO & 2.69 mol/L EG). In EP, the duration of exposure to nVS is of 10 minutes, and 
the duration of the exposure to VS is of 1 minute. In DP, the duration of the exposure to both nVS and VS is of 
1 minute each.
In both protocols, model predictions show that after exposure to nVS, oocytes experiment a fast dehydration, 
shrinking to a minimum of 44.8% of their isotonic volume after 29.4 seconds of exposure. At the end of the expo-
sure to nVS in DP, after 1 minute, equilibration has barely started, with the volume increasing to 48.6%. In the 
EP, exposure to nVS is prolonged to 10 minutes to allow for equilibration, and the oocyte furtherly swells back 
to 79.4% of its isotonic volume. Intracellular osmolarity, however, is very similar after either 1 or 10 minutes of 
exposure to nVS (Table 1 & Fig. 1).
Models show the oocyte subjected to the EP shrinking to 49.9% of its isotonic volume after 1 minute of expo-
sure to the VS, whereas oocytes subjected to DP, with a previous shorter exposure to nVS, are predicted to shrink 
to 39.2%. Similar total intracellular molarity is achieved at the end of EP and DP, with 5.40 and 5.37 mol/L, 
respectively. However, in the EP, permeant cryoprotectants Me2SO and EG contribute to 92.5% of the intracel-
lular molarity, vs. 88.5% in the DP protocol. The normalized water volume, on the other hand, is lower after DP 
compared to EP (17.7 vs. 26.6, respectively; Table 1).
In vitro oocyte osmotic behaviour. The in vitro recordings of human oocytes exposed to EP and DP 
show the osmotic response of the oocytes to nVS and VS. The oocytes begun the experiment at an isosmotic 
condition of 290 mOsmol, and they were directly exposed to the hyperosmotic condition of nVS (2901 mOsmol). 
This osmotic gradient resulted in a volumetric excursion: the minimum relative volume attained was 60% of 
the oocyte’s initial volume in nVS; it took slightly longer than predicted to do so, from 40 to 60 seconds in both 
groups, likely due to the slight dilution of the solution during manipulation. Oocytes subjected to EP recovered 
77% of its initial volume after 10 minutes of exposure to nVS, while oocytes subjected to DP remained at 61% at 
the end of the 1 minute exposure to nVS.
Following the exposures of different duration to nVS, the oocytes in both groups were exposed for 1 minute to 
the more concentrated VS (7068 mOsmol). The hyperosmotic conditions again provoke the shrinking of the cells, 
to 67% in the case of EP oocytes and to 52% of their initial volume in DP oocytes.
Survival and viability of human oocytes and zygotes to vitrification and warming after the 
short dehydration protocol. As shown in Table 2, all of the oocytes and zygotes subjected to the experi-
mental vitrification protocol DP were positive for survival (30/30 and 27/27, respectively). The observed survival 
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of the oocytes was compared to the expected benchmark outcome of 95% survival in a normal population of 
oocytes, based on recent consensus12. Of 27 tripronuclear zygotes subjected to vitrification with DP, 24 resumed 
development and had cleaved after 24 hours of culture, compared to 25 of 27 fresh tripronuclear zygotes used as 
a control (p = 1).
Figure 1. Results of the biophysical model, showing the history of relative volume and intracellular solute 
concentration of human M-II oocytes with A) DP and B) EP. Relative volume as solid line, intracellular solute 
concentration as dotted line. Exposure to nVS (nVS; 7.5% v/v Me2SO and 7.5% v/v EG) starts at t = 0, and the 
change to VS (VS; 15% v/v Me2SO, 15% v/v EG and 0,5 M sacarose) is demarcated in the X-axis with a vertical 
dotted line. Relative volume equals cell volume by the initial cell volume. Intracellular solute concentration in 
moles of solutes per liter.






contribution to total 
intracellular molarity Cell Volume
Initial Cell Volume
Water Volume
Initial Active Water Volume
(min) mol/L (%) (%) (%)
Equilibration Protocol
nVS 10 2.61 92.1 79.4 63.7
VS 1 5.40 92.5 49.9 26.6
Dehydration Protocol
nVS 1 2.56 83.5 48.6 31.6
VS 1 5.37 88.5 39.2 17.7
Table 1. Key parameters that influence the survival of the oocyte to the vitrification process. Comparison 
between equilibration and dehydration protocols of the results of the 2-P model for relevant osmotic 
parameters. (a) Time elapsed since oocytes are initially exposed to each solution; (b) Intracellular molarity of 
the oocyte; (c) Ratio of Intracellular mol/L of EG + DMSO by the total intracellular molarity; (d) Ratio of the 
oocyte’s volume by the initial isotonic total volume; (e) Water volume in the oocyte as a fraction of the initial 
active water volume of the oocyte. The molarity of nVS and VS is 2,41 mol/L and 5,30 mol/L, respectively.
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Discussion
The survival and viability of unfertilized human oocytes and abnormally fertilized zygotes prepared with the 
dehydration protocol shows that their intracellular solute concentration was sufficiently high for the vitrification 
procedure to be successful at the cooling and warming rates obtained. This outcome was expected according to 
the 2-P model used to predict the osmotic behaviour of human M-II oocytes, as the intracellular molarity was 
similar after the standard EP, with 11 minutes of duration, and the DP, of 2 minutes. However, the exact compo-
sition of the cytosolic milieu, and hence its glass-forming tendency after each preparation protocol may differ. 
For instance, in DP, the contribution of permeating cryoprotectants Me2SO and EG to the final cytosolic solute 
concentration was slightly lower than in EP. On the other hand, EP resulted in lower intracellular free water con-
tent in the oocyte compared to EP. Relevant parameters that determine the glass-forming tendency of the cytosol, 
such as the viscosity of the milieu and the degree of hydrogen bonding between present water and intracellular 
macromolecules, could for this reason differ between oocytes prepared to vitrification with each protocol22,23. 
It should also be considered that we employed a carrier that is reported to produce higher rates of cooling and 
warming than others15,24–30 which may compensate for a possible lower intracellular glass forming tendency in 
the cells after DP9,31.
The protocols to prepare oocytes and embryos for vitrification do not only aim to achieve the appropriate 
intracellular glass-forming conditions, but aim to do so without impairing the ability of oocytes to fertilize and 
develop into viable embryos12. Several factors during preparation for vitrification can be detrimental, such as 
the type and concentration of cryoprotectants employed8, as well as the temperature32,33 and the duration of the 
exposure to these cryoprotectants15,34. Despite the tolerance of oocytes to these factors has been studied, reports 
regarding fertilization and developmental ability are less frequent due to ethical and legal constraints35. However, 
if we consider that several of the preparation protocols that are used daily in clinical practice resemble the EP 
described in this work12,16–18, it could be argued that current vitrification outcomes support the tolerance of the 
human M-II oocyte and embryo to the osmotic and mechanical stresses derived from the osmolarity of the nVS 
and VS employed (2901 and 7060 Osmolal, respectively). For instance, the effect on the meiotic spindle and 
oocyte competence of similar CPA exposure regimes, which according to the biophysical simulation produces 
shrinking to 50% of the oocyte’s isotonic volume, has been assessed on human17 and mice26 satisfactorily.
The osmotic gradient to which the oocytes are subjected in both protocols is very similar, as the final molarity 
after exposure to nVS is almost equivalent in EP and DP. However, the volumetric excursion cells undergo during 
preparation for vitrification are higher during DP: the oocyte is not allowed time to equilibrate and regain water 
and volume, and as a result, the total relative volume of the oocyte at the moment of cooling is lower, compared to 
a standard equilibration protocol (DP vs. EP, Fig. 2). Even if cell shrinkage is desirable, as it results in a more stable 
cytoplasm8, mechanical stress can compromise the developmental potential of oocytes, causing disruption in 
cytoskeleton structures, specially depolymerisation of the meiotic spindle36–39. In fact, the exact osmotic tolerance 
limit of oocytes is unclear40, and it has been conservatively estimated in previous attempts at optimizing prepa-
ration protocols14,41–43. As pointed out by Oda et al.44, fertilized mouse ova tolerate a contraction to 30% of their 
isotonic volume, concluding that shrinking alone is not likely to be the cause for viability impairment or death44. 
Also, certain strategies can be adopted to minimize the mechanical stress of shrinking-swelling45. Ultimately, the 
developmental ability of oocytes and embryos is the indicator of the safety and efficiency of a vitrification proce-
dure46. Preliminary tests in the murine model would be necessary to confirm the validity of the proposed protocol 
for human oocyte and embryo cryopreservation26,44.
The in silico and in vivo analysis of the osmotic behaviour of the human oocyte are not without their lim-
itations. When the relative volume of an oocyte is calculated from a bidimensional static frame-grab of the 
shrinking-swelling process, several assumptions are made, so the permeability parameters extrapolated from 
these observations might not be completely accurate41,47, and they were determined under lower concentrations 
of said CPAs41,48–50. At the higher concentrations employed, the cell could deviate from ideal osmotic behaviour51. 
At those concentrations, CPAs seem to interact with the cytoplasmic phospholipid bilayer and may alter its per-
meability52. Also, the biophysical parameters of oocytes seem to present high intervariability, potentially associ-
ated with many factors43,53. For these reasons, permeability models and in vitro observations might not reflect in 
a completely accurate fashion the biophysical reality of the process.
In spite of these limitations, we found a satisfactory agreement from our in silico and in vitro results, revealing 
that the point of minimum volume of the shrink-swell curve is attained within one minute of exposure to the 
hypertonic solutions employed54. This is relevant because, at this point, the intended osmotic effect of dehy-
dration and CPA permeation was close to completion, with very similar intracellular and extracellular molar-
ity. In consequence, limiting the exposure of the cells to the non-vitrifying and vitrifying hypertonic solutions 
to this point of minimum volume could be a more efficient approach to prepare them for vitrification, com-
pared to the current approach consisting on a prolonged exposure to allow for partial osmotic equilibration 
with the non-vitrifying solution. Under this premise, we were able to successfully reduce the necessary time to 
prepare human oocytes and zygotes for vitrification to two minutes with a standard CPA combination. Similar 
No. of oocytes positive for survival after 2 hours/No. of oocytes subjected to vitrification 30/30 (100)
No. of zygotes positive for survival after 2 hours/No. tripronuclear zygotes subjected to vitrification 27/27 (100)
No. of cleaved embryos after 24 hours/No. tripronuclear zygotes subjected to vitrification 24/27 (88.8)
No. of cleaved embryos after 24 hours/No. of fresh tripronuclear zygotes 25/27 (92,6)
Table 2. Survival and viability of human oocytes and zygotes after preparation for vitrification with the short 
protocol and vitrification with the SafeSpeed carrier.
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time-efficient dehydration-based protocols comprising short exposures to increasingly hypertonic solutions could 
be fine-tuned for its application to other mammalian gametes and embryos, as well as more complex models.
Materials and Methods
Study population. Human Metaphase-II oocytes were chosen for the study as the need for their cryopres-
ervation is rising due to the trend in social fertility preservation55. Also, there is room for improvements in the 
benchmark clinical outcomes as well as the procedure itself12.
Figure 2. In vitro recording of the volumetric excursion of human M-II oocytes subjected to: Dehydration 
protocol (DP); Equilibration Protocol (EP) of preparation for vitrification. Exposure to nVS starts at t = 0, the 
change to VS is demarcated at the X-axis. An example of the oocyte’s morphology at relevant timeframes is 
shown below each graphic.
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In the interest of minimizing the number of biological material employed, previously characterized permea-
bility parameters were used for the biophysical modelling41,48,49,53. With it, we theoretically identified a plausible, 
short dehydration protocol. Then, we validated the data by studying the in vitro osmotic behaviour of human 
M-II oocytes under the conditions used in the simulation. For these experiments, we employed a total of 22 
Metaphase-II human oocytes retrieved in a private IVF setting by ovarian hyperstimulation, that had been dis-
carded for clinical practice due to failed fertilization by ICSI and donated for research. For the subsequent via-
bility assays of the dehydration protocol, we employed again discarded unfertilized human oocytes oocytes, and 
abnormally fertilized human zygotes, showing >2 pronuclei at the fertilization check 17 ± 2 hours post in vitro 
fertilization. These oocytes and zygotes were discarded from clinical practice and donated for research. In order to 
detect, with 80% power and alpha 0.05 a 15% one-sided difference from a benchmark survival rate to vitrification 
of 95%12, 30 oocytes and 27 zygotes were included in the study.
Equilibration protocol and dehydration protocol to prepare M-II oocytes for vitrification. The 
Equilibration protocol (EP) was designed to represent the current standard practice to prepare human 
Metaphase-II oocytes for vitrification: the oocyte is directly exposed to a 7.5% v/v EG and 7.5% v/v Me2SO phos-
phate buffered saline (PBS) solution (non-vitrifying solution, nVS) for 10 minutes. This step is followed by a direct 
exposure to a 15% v/v EG, 15% v/v Me2SO and 0.5M sucrose PBS solution (vitrifying solution, VS) with 1 minute 
of duration. The Dehydration protocol (DP) is a modification of the Equilibration protocol, in which the exposure 
of the oocyte to both solutions nVS and VS is limited to 1 minute each.
Cooling and warming to cryogenic temperatures in liquid nitrogen. For the viability experiments, 
oocytes and zygotes were prepared for vitrification following the short dehydration protocol (DP) and loaded in 
a closed vitrification carrier (Safepreservation, Spain), which was sealed hermetically in both ends prior to a fast 
plunging in liquid nitrogen. Note that the loading, sealing and cooling of the vitrification device were performed 
during the 60 seconds of exposure to VS, and not afterwards. The process of loading the vitrification carrier is 
described thoroughly elsewhere24.
For warming, the capillary was transferred to a 37 °C water bath, stirred for two seconds, dried in sterile cloth 
and its tip cut, releasing the oocytes in a 1M sucrose solution. After 60 seconds, oocytes were transferred to a 
0.5M sucrose solution for three minutes and eventually placed for 5 minutes in a CPA-free solution. According to 
previous published measurements employing the same closed vitrification carrier, the zygotes were subjected to 
warming rates of 200.000 °C/min24.
Modelling membrane permeability of the human M-II oocytes. The two-parameter transport formal-
ism model. The two-parameter (2P) transport formalism has been used in this work to perform the necessary 
simulations to analyse the oocytes’ mass transfer dynamics in the presence of permeable and non-permeable 
solutes20. This model evaluates the flow of water and solutes through the cell membrane with a pair of coupled 
linear ordinary differential equations, assuming that there is no intermembrane interaction between water and 
the permeable solutes. Nevertheless, there are publications that have shown that the interaction factor or reflec-
tion coefficient (σ) of the 3-parameter Kedem-Katchalsky formalism is insignificant in many membranes, oocytes 
included47,56.
The 2-P model characterises the permeability of the membrane to water with the parameter Lp (hydraulic 
conductivity), and the permeability of the membrane to penetrant solutes with the parameter Ps, namely solute 
permeability. It is well known that permeability depends on temperature, and it is very common to define this 
relationship through an Arrhenius Eq. (1):













the water transfer dynamics are defined by the Eq. (2)
dVw
dt
L A R T M M( ) (2)p
e i= − ⋅ ⋅ ⋅ ⋅ −
the permeable solute transfer dynamics is defined by the following Eq. (3):
= ⋅ ⋅ −
dNs
dt




In our particular case, we will need to define two solute equations, one for Me2SO and another for EG. This 
means that we will have to solve a system of three linear ordinary differential equations, with three parameters: 
Vw, NDMSO and NEG (Supplementary Table 1).
In silico analysis of the equlibration and dehydration protocols. In order to solve the system of differential equa-
tions, we developed specific software in MATLAB (Version R2014A, Mathworks, USA). In particular we employ 
the built-in function ODE45 based on the Runge-Kutta method.
The oocyte was assumed to be of perfect spherical shape, with a radius of 63 µm, and the osmotically inactive 
volume of the oocyte was considered to be 19% of its initial volume48. Values for the permeability of the cell 
membrane to water (hydraulic permeability; Lp), and to permeating cryoprotectants Me2SO and EG, and their 
respective activation energy (Ea), were used as previously estimated41,49,57–59 (Supplementary Table 2).
As in previous cell dynamic modelling studies, some simplifying assumptions were made: (i) the oocyte 
remained in perfect spherical shape during shrinking and swelling, with an area determined by the cell radius 
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(A = 4 * π * r2); (ii) the solutions are ideal; (iii) hydrostatic pressure is zero; (iv) the osmotic coefficient for solutes 
are equal to 1, except for common salt (NaCl), with molalities and osmolalities equivalent and linear additivity of 
solute’s osmolalities. The cytosol was considered to contain only water and common salt (NaCl)41,48,60.
First, a simulation of a standard vitrification preparation protocol in which cell are left to equilibrate in the 
first solution (equilibration protocol, EP) was run. A second simulation was run with the shorter preparation 
protocol (dehydration protocol, DP), for which the exposure of the oocyte to both solutions nVS and VS is lim-
ited to 1 minute each. Key parameters for oocyte survival to vitrification, such as the volumetric excursion of the 
oocyte, intracellular active water content, and total cytosolic solute concentration were determined and compared 
between the two approaches.
In vitro oocyte osmotic behaviour. To determine if the model predictions were accurate, the in silico 
dehydration profiles obtained with the theoretical models were reproduced with in vitro observations of the 
osmotic behaviour of human oocytes exposed to the standard and short preparation protocols.
Perfusion with CPA solutions. Drops of 2 µL of iso-osmotic PBS, 200 µL of nVS and 2 mL of VS were placed 
near contact in a 60 mm Petri dish. The Petri dish was placed on a heated stage at 25 °C (INUG2H-TIZSH, Tokai, 
Japan) on an inverted microscope (Ti-U, Nikon, Japan) with an assembled micromanipulator (Narishige, Japan). 
For each experiment, an oocyte was placed in the PBS drop with a capillary, and secured by suction of the zona 
pellucida by a holding pipette (MPH-MED-30, Origio, Denmark). To avoid desiccation, time between oocyte 
placement and perfusion of the solutions was minimized. The PBS drop and adjacent nVS drop were merged 
with the tip of the capillary to start the osmotic process. Once the exposure time to nVS was complete, the drop 
was merged with the adjacent VS drop. EP and DP protocols were replicated until we recorded five oocytes that 
retained a spherical morphology and presented fewer folds and creases during shrinking. Of a total of 22 oocytes 
subjected to the experiment, 5 replicates of each protocol were selected for analysis and calculation of the cyto-
plasmic area. Solutions were provided by SafePreservation (Spain).
Image acquisition and quantitative analysis of dehydration. The process was recorded in a PC (Software X) with a 
video acquisition system connected to the inverted microscope (Sony, Japan), using 400X magnification. A video 
frame of every ten seconds for the first minute of exposure on DS1 and DS2, and every 60 seconds after the first 
minute for the 10 minute exposure to DS1 was extracted and analyzed to determine the volumetric excursion of 
the oocyte relative to the initial isotonic volume. Still images of the oocytes were processed to determine their area 
for volume calculation, as described by41. To reduce skewing by irregularities in the spherical shape of the oocyte 
during shrinking, the radius was calculated from the oocyte’s bidimensional area, and then used to determine the 
oocyte’s volume, assuming a perfect spherical shape maintained throughout the process.
Survival and viability of human oocytes and zygotes to vitrification and warming after the 
short dehydration protocol. The survival of the oocytes and zygotes was assessed two hours after complet-
ing the warming and rehydration process: those whose morphological appearance remained similar to fresh after 
vitrification were considered positive for survival12. As an additional viability indicator, post-warming mitosis 
resumption and cleavage was assessed after 24 hours of culture. Results were compared with a control group of 27 
abnormal zygotes not subjected to vitrification. Embryo culture was carried out in pre-equilibrated embryotested 
60 mm petri dishes (Falcon, Corning, USA), containing 30 µl drops of G1-Plus medium (Vitrolife, Sweden) with 
a mineral oil overlay at 37 °C and 6% CO2.
Ethical approval and informed consent. The protocol of the study involving human material was 
reviewed and approved by a biomedical research ethics committee (CEI de los Hospitales Universitarios Virgen 
Macarena y Virgen del Rocío; Internal code 1123-M1-17). Informed consent was obtained from all participants 
and the protocol was in accordance with national guidelines and regulations.
Data availability
The data that support the findings of this study are available from the corresponding author, R.R., or the first 
author, M.G., upon reasonable request.
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